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Abstract
p62/SQSTM1 (sequestosome1) has never been evaluated in oral epithelium. In order to clarify the role of p62/SQSTM1 in
carcinogenesis in oral epithelium, both p62/SQSTM1 and Nrf2 were immunohistochemically evaluated in 54 carcinomas and
14 low grade dysplasias. p62/SQSTM1 knockdowns were also designed in oral cancer cells, and we analyzed the Nrf2
pathway, GSH contents and ROS accumulation. The association between p62/SQSTM1 excess and prognosis was addressed
in a clinical cohort of oral carcinoma cases. p62/SQSTM1 excess was more obvious in carcinomas, but Nrf2 was abundant in
almost all samples of the oral epithelium. In oral carcinoma cells, p62/SQSTM1 knockdown did not affect the Nrf2-Keap1
pathway but did significantly reduce GSH content with subsequent ROS accumulation, and caused cell growth inhibition in
the irradiated condition. Finally, p62/SQSTM1 excess was associated with poor prognosis in a clinical cohort. In oral
epithelial carcinogenesis, p62/SQSTM1 excess played a role in GSH induction rather than Nrf2 accumulation, and may cause
resistance to cytotoxic stresses such as radiation or chemotherapy. Immunohistochemical evaluation of p62/SQSTM1 may
be a potential significant marker to identify early carcinogenesis, chemo-radiotherapeutic resistance or poor prognosis of
oral squamous cell carcinomas.
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Introduction
p62/SQSTM1 (sequestosome1) was isolated by cDNA library
screening with autoantibody from patients with hepatocellular
carcinoma (HCC) [1]. p62/SQSTM1 is stained in some
carcinomas such as HCC [2,3], intestinal carcinomas [4], anal
carcinoma [5], and prostate carcinoma [6]. However, p62/
SQSTM1 expression has never been evaluated in oral carcinomas
and epithelia, and the contributed functions have never been
analyzed in oral epithelial carcinogenesis.
Head and neck squamous cell carcinoma, such as oral
carcinoma, is one of the carcinomas that are maximally associated
with oxidative stress, and continuous oxidative stress can promote
oncogenesis. Head and neck epithelium is often exposed to
tobacco and alcohol, both sources of massive quantities of reactive
oxygen species (ROS), which have been clearly identified as
etiologic factors in these malignancies [7,8]. Environmental and
endogenous oxidative/electrophilic agents induce nuclear factor
E2-related factor 2 (Nrf2), which is a master transcriptional
activator of genes encoding numerous cytoprotective enzymes [9].
Accumulative Nrf2 mutations have been frequently observed in
head and neck cancers, and Nrf2 is abundantly expressed in
normal squamous epithelium in the regions. Therefore, aberra-
tions of the Nrf2 pathway might play an important role in tissues
exposed to abundant ROS, such as oral, nasopharyngeal, and
tracheal epithelium [10]. Accumulative Nrf2 is currently recog-
nized as one of the main cellular defense mechanisms against
oxidative and electrophilic stresses [11–13]. Under quiescent
conditions, the transcription factor Nrf2 is constitutively degraded
through the ubiquitin-proteasomal pathway because its binding
partner, kelch-like ECH-associated protein 1 (Keap1) is an
adaptor of the ubiquitin ligase complex [14–17]. Exposure to
electrophiles, ROS or nitric oxide instigates modification of the
cysteine residues of Keap1, leading to its inactivation [18–20]. As a
result, Nrf2 becomes stabilized and translocates to the nucleus to
induce the transcription of numerous cytoprotective genes,
including NAD(P)H dehydrogenase quinone 1 (NQO1), haem
oxygenase-1 (HO-1) and glutathione S-transferase (GST) [21–24].
Excessive p62/SQSTM1 accumulates and binds to Keap1 in
competition with Nrf2. Then, abundant, stabilized Nrf2 can
induce the associated antioxidant proteins (NQO1 and HO-1)
[25].
In the present study, p62/SQSTM1 excess was demonstrated in
the oncogenic progression of oral squamous cell carcinoma, but
Nrf2 was expressed in almost all samples of the oral epithelium. In
order to analyze the roles of p62/SQSTM1 and the Nrf2-Keap1
pathway in oral epithelial carcinogenesis, oral cancer cells and
p62/SQSTM1 knockdown variants were utilized. In this study we
discovered an association between p62/SQSTM1 excess and poor
clinical survival, and we propose that p62/SQSTM1 may be a
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potential novel predictive biomarker in the chemo-radiotherapeu-
tic management of oral carcinoma cases.
Materials and Methods
Tissue samples and pathological data
Fifty-four primary oral squamous cell carcinomas and fourteen
low grade dysplasias were obtained by biopsy at Shiga University
of Medical Science. Patients with carcinoma comprised 32 males
and 22 females with a median age of 64.8 years (27–92 years). The
carcinoma specimens were removed from tongue (22 cases), gum
(17 cases), buccal mucosa (4 cases), floor of mouth (4 cases), plate (2
cases) and lip (2 cases) tissues. Tumor classifications consisted of 23
cases of T1, 24 cases of T2, 2 cases of T3 and 5 cases of T4 (Table
1). Patients with low grade dysplasia comprised 8 males and 6
females with a median age of 56.9 years (29–82 years). The low
grade dysplasias were removed from tongue (7 cases), gum (5
cases), buccal mucosa (1 case) and plate (1 case) tissues (Table 2).
These cases were independent from carcinoma patients. Twenty-
nine specimens of non-atypical epithelium consisted of lesions in
separate regions of the specimens of cancers and dysplasias. Data
were collected from clinical and pathological records with the
written informed consent of individual patients and after approval
by the Ethics Committee of Shiga University of Medical Science
(Ethical Proof Number #22-105).
Antibodies
Anti-p62/SQSTM1 (5F2) was obtained from MBL (Aichi,
Japan). Anti-Nrf2 for immunohistochemistry (ab31163), anti-
NQO1 (ab28947), anti-HO-1 (ab13248) and anti-Glutathione
(gamma-glutamyl-cysteinyl-glycine, GSH; ab19534 [D8]) were
obtained from Abcam (MA, US). Anti-phospho Nrf2 (pS40: 2073-
1) for Western blot, which recognized the active nuclear form of
Nrf2, was obtained from EPITOMICS (CA, US). Anti-Keap1
(10503-2-AP) was obtained from PROTEINTECH (IL, US). Anti-
a-tubulin (DM 1A) was obtained from SIGMA (MO, US).
Immunohistochemistry
Surgical specimens were transferred to 10% buffered formalin
and fixed overnight. The fixed samples were embedded in
paraffin, and serially sliced into 5mm sections. After dewaxing,
sections were autoclaved at 120uC for 1min in 10 mM sodium
citrate buffer (pH 6.0), and immersed in 0.3% H2O2. They were
then incubated overnight at 4uC with primary antibodies to p62/
SQSTM1 (diluted 1:500) or Nrf2 (diluted 1:200). The sections
were rinsed with 16PBS and incubated with the secondary
antibody conjugated with horseradish peroxidase (Simple Stain
MAX-PO; Nichirei, Tokyo, Japan) at room temperature for 1
hour. The sections were then stained with 3.39-diaminobenzidi-
netetrahydrochloride (DAB) and counter-stained with hematoxy-
lin. Xenografted human squamous cell carcinoma was treated
with anti-cancer agents [26], and used for the positive control
specimen. Non-immunized mouse or rabbit IgG was substituted
for each primary antibody to serve as a negative control specimen.
The staining was evaluated on a case-by-case basis by two blinded
independent observers. A positive expression of p62/SQSTM1 or
Nrf2 was defined when the cytoplasm and/or nuclei were stained
with DAB. The staining grades were classified by the percentage of
stained cells as follows: (–), the positive cells comprised ,10%; (6),
10–20%; (+), .20%; (++), additional strong staining such as
aggregation and nuclear accumulation, etc. In addition, ++/+ and
6/– were categorized as high and low expressions, respectively
(Table 3). In 29 cases of non-atypical epithelium, the staining
grades of non-atypical epithelium were compared with those of
carcinomas or low grade dysplasias.
Proximity ligation assay
Proximity ligation assay (PLA) [27] was performed with Duolink
II PLA probes and Detection Reagents Brightfield kit (Olink
Bioscience, Uppsala, Sweden), following the manufacturer’s
instructions. Tissues were deparaffinized, autoclaved, immersed
in 0.3% H2O2 and incubated with overnight at 4uC with primary
antibodies to p62/SQSTM1 (diluted 1:2000), Nrf2 (diluted
1:1000) or GSH (diluted 1:6000). PLUS and MINUS secondary
PLA probes against mouse, rabbit or mouse IgG, respectively,
were applied sequentially followed by hybridization, ligation,
amplification and HRP/NovaRed detection solution. Image
analysis was conducted as described previously [28]. Representative
pathological regions of each case were reviewed by two pathology
specialists (M.T. and H.O.), and 3–4 typical regions of each case
were digitally photo-imaged. PLA signals of every image were
counted semi-automatically (Figure S1) using the freely distributed
software BlobFinder, which has been developed by the Centre for
Image Analysis at Uppsala University (http://www. cb.uu.se/
,amin/BlobFinder/). Mean PLA signals from 3–4 images of each
case were recognized as the case-originated values (RCPs/cell).
Cell cultures
The cancer cell line SAS (human oral carcinoma) was
purchased from Riken Cell Bank (Ibaraki, Japan). HeLa (human
endocervical carcinoma) and CAL27 (human oral carcinoma)
were from American Type Culture Collection. TIG-108 and –121
(human normal fibroblasts) were from the Japanese Collection of
Research Bioresources. These cell lines were cultured in
Table 1. Clinico-pathological parameters of the patients with
oral squamous cell carcinomas.
Characteristics No ( %)
Cases 54
Average age at diagnosis 64.76
Gender
Male 32 (59.3)
Female 22 (40.7)
Tumor classification (T-stage)
1 23 (42.6)
2 24 (44.5)
3 2 (3.7)
4 5 (9.3)
Histological differentiation
Well differentiated 43 (79.6)
Moderately differentiated 8 (14.8)
Poorly differentiated 3 (5.6)
Location
Tongue 22 (40.7)
Gum 17 (31.5)
Buccal mucosa 7 (13.0)
Floor of mouth 4 (7.4)
Palate 2 (3.7)
Lip 2 (3.7)
doi:10.1371/journal.pone.0074398.t001
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Dulbecco’s modified Eagle’s medium containing 10% fetal bovine
serum (DMEM/10%FBS). Cell culture media were supplemented
with penicillin (50 units/mL) and streptomycin (50 mg/mL).
These cell lines were incubated at 37uC in a humidified chamber
supplemented with 5% CO2.
X-ray irradiation
For an X-ray irradiation treatment, subconfluent oral cancer
cells of SAS and CAL27 in 6 well plates or 96 well plates
containing DMEM/10%FBS were exposed to X-rays (2Gy/min)
using a 150-kVp X-ray generator (Model MBR-1520R, Hitachi,
Tokyo, Japan) with a total filtration of 0.5 mm aluminum filter,
plus a 0.1 mm copper filter, and then incubated at 37uC in a
conventional humidified 5% CO2 incubator.
Protein extractions and Western blot analysis
The expressed proteins of each cell line were analyzed by
immunoblotting. Cells were ruptured in ice-cold lysis buffer
(40 mM HEPES (pH 7.5), 120 mM NaCl, 1 mM EDTA, 10 mM
pyrophosphate, 10 mM glycerophosphate, 50 mM NaF, 0.5 mM
orthovanadate, and EDTA-free protease inhibitors; Roche)
containing 1% Triton X-100. Cell extracts were kept on ice for
20 minutes and centrifuged at 12,000 rpm for 10 minutes (4uC).
The supernatants were boiled with SDS sample buffer. Proteins
separated by SDS-PAGE were transferred to polyvinylidene
difluoride filters. After blocking of the filters with TBS-T
(10 mM Tris-HCl (pH 7.6), 150 mM NaCl, 0.1% Tween 20)
containing 5% bovine serum albumin (BSA), the filters were
incubated for 1 hour with the primary antibodies in TBS-T
containing 2% BSA. The filters were then washed in TBS-T and
incubated for 30 minutes in horseradish peroxidase-conjugated
anti-mouse or anti-rabbit immunoglobulin G (GE Healthcare, US)
diluted 1:10,000 in TBS-T containing 2% BSA. After several
washes with TBS-T, immunoreactivity was detected by the ECL
system (GE Healthcare, US) according to the procedures
recommended by the manufacturer.
Preparation of recombinant lentiviruses encoding p62/
SQSTM1 shRNA
Vectors for sh-RNA of p62/SQSTM1 (sh-p62(1) and (2)) and of
nonsilencing control (sh-control) were purchased from Open-
Biosystems (CA, US). Mature antisense sequences for p62/
SQSTM1 were ATCAACTTCAATGCCCAGAGG and
TTCTCTTTAATGTAGATTCGG, respectively (available at
Thermo Scientific Bio, Web site). Lenti-virus for transferring each
sh-RNA was prepared with each packaging mixture, according to
the manufacturer’s instruction. SAS and CAL27 cells transferred
by .10 MOI of each lenti-virus were selected in the presence of
3 mg/ml puromycin, expanded and used in the experiments.
WST-8 assay for cell viability
SAS and CAL27 cells were cultured in 96-well plates at a
density of 16103 per well, and cell viability assays were carried out
by a Cell Counting Kit-8 (Dojindo Molecular Technologies Inc,
Kumamoto, Japan). WST-8 reagent solution was added to each
well, and the absorbance at 450 nm (OD450) was then measured
by a microplate reader after the microplate was incubated with the
reagent for 3 hours at 37uC, in accordance with the manufactur-
er’s instructions.
GSH and GSSG assay
Glutathione (GSH) and Glutathione-S-S-Glutathione (GSSG)
were determined with a quantification kit (Dojindo Molecular
Technologies Inc) according to the manufacturer’s instructions.
The variously treated cells were lysed by the addition of 80 mL of
10 mM HCl and by freezing and thawing twice. To the
homogenate was added 20 mL of 5% salicylsalicylic acid (SSA),
and the mixture was centrifuged at 8,000xg for 10 minutes. GSH
and GSSG levels in the supernatant were determined according to
the manufacturer’s protocol by measuring absorbance at 405 nm
with a microplate reader.
ROS and DNA assays
ROS and DNA levels were detected with CellROXH Green
reagent and Hoechst 33342 reagent (Life technologies, CA, US)
containing excitation/emission at 485/520 nm and 352/461 nm,
respectively. The cells were stained with 5 mM of CellROXH
Green Reagent and 5 mg/ml of Hoechst 33342 reagent by adding
the probe to the complete medium and incubating the cells at
37uC for 30 minutes. The cells were then washed with PBS,
harvested by trypsin, immersed with Live cell imagingH reagents
(Life technologies, CA, US), and analyzed on AttuneH Acoustic
Focusing Cytometer (Life technologies).
Statistical analysis
To evaluate PLA signal differences statistically among non-
atypical epithelium, low grade dysplasia and carcinoma; and to
analyze assays for WST-8, GSSG and GSH among sh-RNA
Table 3. Summary of the classical immunohistochemical
staining scores.
p62/SQSTM1 and Nrf2
High ++ .20% with aggregation or nuclear accumulation
+ .20%
Low 6 10–20%
- ,10%
doi:10.1371/journal.pone.0074398.t003
Table 2. Clinical parameters of the patients with low grade
dysplasias.
Characteristics No (%)
Cases 14
Average age at diagnosis 56.86
Gender
Male 8 (57.2)
Female 6 (42.9)
Location
Tongue 7 (50)
Gum 5 (35.7)
Buccal mucosa 1 (7.2)
Palate 1 (7.2)
doi:10.1371/journal.pone.0074398.t002
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treated cells, one-way factorial ANOVA and multiple comparison
tests accompanied by Scheffe’s significance test were applied. To
explore the clinical prognostic significance of p62/SQSTM1
excess, disease-specific survival curves were estimated by the
Kaplan-Meier method with a log-rank test and the chi-square test.
A p-value of ,0.05 was considered statistically significant. All the
statistical analyses were performed with StatView Version 5.0 for
Windows (SAS institute Inc).
Figure 1. p62/SQSTM1 was abundantly stained in oral squamous cell carcinomas. (A) Case-frequencies (%) of p62/SQSTM1 staining grades
in oral squamous cell carcinomas (blue columns; 54 cases), low grade dysplasias (red columns; 14 cases) and non-atypical epithelia (green columns; 29
cases). (B) Means 6 S.E. of PLA signals for p62/SQSTM1 are displayed as bar graphs. The values (RCPs/cell) are 9.9560.89, 3.9060.48, 2.0560.69 and
1.9560.30 in the highest expression grade (++) carcinomas (24 cases), other carcinomas (30 cases), low grade dysplasias (14 cases) and non-atypical
epithelia (29 cases), respectively. There was a significant difference between the highest expression grade (++) carcinomas and the other categories
(p,0.0001), using one-way factorial ANOVA and multiple comparison tests accompanied by Scheffe’s significance test. (C) Representative findings of
p62/SQSTM1 staining in the highest expression grade (++) carcinoma (left), in low grade dysplasia (middle), and in non-atypical epithelium (right).
Corresponding PLA signals and BlobFinder images are displayed in the middle and lower rows, respectively. Scale bar; 100 mm.
doi:10.1371/journal.pone.0074398.g001
p62/SQSTM1 and Oral Carcinogenesis
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Figure 2. Nrf2 was abundantly expressed in carcinomas, low grade dysplasias, and non-atypical epithelia of oral tissue. (A) Case-
frequencies (%) of Nrf2 staining grades in oral squamous cell carcinomas (blue columns; 54 cases), low grade dysplasias (red columns; 14 cases) and
non-atypical epithelia (green columns; 29 cases). (B) Means 6 S.E. of PLA signals for Nrf2 are displayed as bar graphs. The values (RCPs/cell) are
2.3260.20, 2.1060.32 and 1.2460.17 in carcinomas (54 cases), low grade dysplasias (14 cases) and non-atypical epithelia (29 cases), respectively.
There was a significant difference between carcinomas and non-atypical epithelia (p= 0.0029), using one-way factorial ANOVA and multiple
comparison tests accompanied by Scheffe’s significance test. (C) Representative findings of Nrf2 staining in carcinoma (left), in low grade dysplasia
p62/SQSTM1 and Oral Carcinogenesis
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Results
p62/SQSTM1 excess was more obvious in oral squamous
cell carcinomas than in low grade dysplasias or non-
atypical epithelia
Clinical characteristics of the patients are summarized in
Tables 1 and 2. The present cohort represented a population that
was similar to that in the previous study [29]. In order to analyze
the contribution of p62/SQSTM1 to carcinogenesis in oral
carcinoma cases, expressional evaluation of p62/SQSTM1 was
performed immunohistochemically. The case-frequency of im-
munohistochemical p62/SQSTM1 grades is summarized in a
column graph. High-expression cases of p62/SQSTM1 were
more frequently seen in oral squamous cell carcinomas than in
low grade dysplasias or non-atypical epithelia. More than half of
the cases in low grade dysplasias and in non-atypical epithelia
were categorized as low expression. In contrast, only two cases
(3.7%) were labeled as low expression in carcinomas (Figure 1A).
In each specimen, PLA signals for p62/SQSTM1 were signifi-
cantly increased in the carcinomas, especially in the highest
expression grade (++) lesions (One-way factorial ANOVA and
multiple comparison tests accompanied by Sheffe’s significance
test, p,0.0001; Figures 1B and 1C). Taken together, the results
indicated that excessive p62/SQSTM1 was more significantly
prominent in oral squamous cell carcinomas than in low grade
dysplasias or non-atypical epithelia.
Nrf2 was abundantly expressed in all the carcinomas, low
grade dysplasias and non-atypical epithelia of oral tissues
We examined Nrf2 expression immunohistochemically in
order to evaluate its contribution to oral epithelial carcinogen-
esis. Nrf2 was abundantly expressed in all the samples of oral
epithelia, ranging from normal epithelium to carcinoma. Almost
all cases were categorized as high expression, and negative cases
were never detected in any of the oral epithelia samples (Figure
2A). Quantified PLA signals for Nrf2 were significantly higher in
carcinomas than in non-atypical epithelia (p= 0.0029), but not
higher than that in low grade dysplasias (p= 0.8313, one-way
factorial ANOVA and multiple comparison tests accompanied
by Scheffe’s significance test; Figures 2B and 2C). There was a
weakly positive correlation between p62/SQSTM1- and Nrf2-
PLA signals (Pearson’s correlation coefficient, r = 0.245, n = 97,
p= 0.0265; Figure 2D). Glutathione (GSH) levels were addi-
tionally quantified by PLA in the clinical samples of oral
epithelium, and then a stronger positive correlation between
p62/SQSTM1- and GSH- PLA signals was significantly
detected (Pearson’s correlation coefficient, r = 0.588, n = 97,
p,0.0001; Figure 2E).
p62/SQSTM1 knockdowns had little effect on Nrf2-Keap1
pathway in oral cancer cells
p62/SQSTM1 was highly expressed in oral cancer cells of SAS
and CAL27 compared with expression in human fibroblasts (TIG-
108 and -121; Figure 3A). Excessive p62/SQSTM1 binds to
Keap1 competitively with Nrf2, and can cause induction of the
antioxidant proteins (NQO1 and HO-1) [25]. Therefore, to
explore p62/SQSTM1 contribution to the Nrf2-Keap1 pathway,
knockdowns were designed in two kinds of oral cancer cells, SAS
and CAL27. p62/SQSTM1 was significantly depressed by the
shRNA (sh-p62 (1) and sh-p62 (2)). Keap1 was abundantly
detected by sh-RNAs for p62/SQSTM1 under 10 Gy X-ray
irradiation, although the expression was not significantly changed
under normal conditions. However, expressions of active Nrf2,
NQO1 and HO-1 were subtly affected by p62/SQSTM1
knockdown, and no significant constant effect was detected under
normal or 10 Gy X-ray irradiated conditions (Figure 3B). The data
suggested that the role of p62/SQSTM1 could not be adequately
explained in the cascade from Nrf2-Keap1 to NQO1 and HO-1.
Under irradiation, cancer cell growth was significantly
inhibited by p62/SQSTM1 knockdown in oral cancer cells
The growth of oral cancer cells treated with shRNA (sh-control,
sh-p62 (1) and sh-p62 (2)) were evaluated under conditions with/
without X-ray irradiation. Under 5 and 10 Gy X-ray irradiation,
shRNAs for p62/SQSTM1 (sh-p62(1) and sh-62(2)) caused
significant growth inhibition, although the effects were partial
under normal culture conditions (one-way factorial ANOVA and
multiple comparison tests accompanied by Scheffe’s significance
test, p,0.05; Figure 3C). These data suggested that p62/
SQSTM1 played a more important role in the survival of
irradiation than in normal conditions.
p62/SQSTM1 knockdowns significantly reduced GSH
content in oral cancer cells
To evaluate whether p62/SQSTM1 was essential to induce a
GSH response to X-ray irradiation, GSSG and GSH levels were
analyzed in p62/SQSTM1-knockdown oral cancer cells. GSSG
levels were increased in the knockdown cells of SAS (sh-p62(1) and
sh-p62(2); red and brown columns; Figure 4A). Under no
irradiation, GSH levels were mildly affected by p62/SQSTM1
knockdown in oral cancer cells (Figure 4A). GSH was significantly
reduced under 5-10 Gy X-ray irradiation in both oral cancer cells
treated with shRNAs for p62/SQSTM1 (sh-p62(1) and sh-p62(2);
red and brown columns), although it was maintained under 5-10
Gy X-ray irradiation in the control shRNA cells (sh-control; blue
columns; one-way factorial ANOVA and multiple comparison
tests accompanied by Scheffe’s significance test, p,0.05; Figure
4A). These data indicated that p62/SQSTM1 was significantly
involved in GSH maintenace in oral cancer cells.
ROS levels were significantly increased and catastrophic
growth-inhibition was promoted by p62/SQSTM1
knockdown in oral cancer cells
In order to analyze whether more ROS was accumulated in
p62/SQSTM1-knockdown cells, ROS levels were quantified in
the knockdown and control variants of SAS and CAL27 oral
cancer cells. ROS levels were higher in p62/SQSTM1-knock-
down cells (sh-p62; red lines) than in the control oral cancer cells
(sh-control; blue lines) under all the irradiated conditions (Figure
4B). The cells containing high amounts of ROS were prominently
detected under 10 Gy X-ray irradiation in sh-p62 cells (Figure 4B).
Sub-G1 apoptotic fractions could not be detected in SAS and
CAL27 oral cancer cells. However, in cells that were more
irradiated, accumulation of .G2/M phase cells became more
prominent. The accumulation was more siginificant in p62/
SQSTM1-knockdown cells (sh-p62; red lines) than in the control
(middle), and in non-atypical epithelium (right). Corresponding PLA signals are displayed in the lower row. Scale bar; 100 mm. (D) There was a weakly
positive correlation between p62/SQSTM1- and Nrf2- PLA signals (Pearson’s correlation coefficient; r = 0.245, n = 97, p= 0.0265). (E) There was a
strongly positive correlation between p62/SQSTM1- and GSH-PLA signals (Pearson’s correlation coefficient; r = 0.588, n = 97, p,0.0001).
doi:10.1371/journal.pone.0074398.g002
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Figure 3. p62/SQSTM1 knockdown had little effect on the Nrf2-NQO1 pathway in oral cancer cells. However, p62/SQSTM1 knockdown
affected the growth of the cells. (A) p62/SQSTM1 was abundantly expressed in SAS and CAL27 oral cancer cells. HeLa, endocervical carcinoma cells;
TIG-108 and 121, normal human fibroblasts. (B) p62/SQSTM1 knockdown was performed by two kinds of shRNAs (sh-p62(1) and sh-p62(2)). shRNA for
luciferase was used as control knockdown (sh-control). p62/SQSTM1 expression was significantly decreased by sh-p62(1) and sh-p62(2). Under no
irradiation or 10 Gy X-ray irradiation, expressions of Nrf2 (pS40), Keap1, NQO1 and HO-1 were subtly affected by p62/SQSTM1 knockdown. Similar
amounts of each cell protein were loaded in each lane of the SDS-PAGE. a-tubulin was used a loading control. Left and right panels indicate the data
on SAS and CAL27, respectively. Three independent experiments were repeated, and the blotting photographs are representative ones. (C) p62/
SQSTM1 knockdowns and X-ray irradiation were similarly performed. No radiation (upper); The effects of shRNA (sh-p62(1) and sh-p62(2)) were partial
under normal culture condition. X-ray irradiations of 5 Gy (middle) and 10 Gy (lower); The cancer cell growth was significantly inhibited by two kinds
p62/SQSTM1 and Oral Carcinogenesis
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cells (sh-control; blue lines; Figure 4C). Both the prominent
accumulation of .G2/M phase cells and the growth-inhibition
suggested mitotic catastrophe, which is one type of cell death that
may occur after irradiation. The data on two kinds of p62/
SQSTM1 knockdown cells (sh-p62(1) and sh-p62(2)) were quite
similar in all the conditions, so the data on sh-p62(1) cells are
shown as representative examples.
p62/SQSTM1 excess indicated an important clinical
relevance in oral cancer
Finally, we evaluated whether p62/SQSTM1 excess was
associated with poor prognosis in a clinical cohort. Forty-seven
cases of oral cancer could be immunohistochemically evaluated
and followed-up clinically. The association between p62/
SQSTM1 staining and clinical disease-specific survival was
evaluated statistically in the Kaplan-Meier curve together with
log-rank analysis (Figure 5). The immunohistochemical status of
p62/SQSTM1 could predict the clinical prognosis of oral cancer
cases, and the cases with strong p62/SQSTM1 staining showed
the worse prognoses with regard to a 2-year survival.
Discussion
The present study has demonstrated for the first time that an
abnormal excess of p62/SQSTM1 is present in oral squamous
carcinoma cells. The p62/SQSTM1 excess was more obvious in
oral carcinomas than in low-grade dysplasias or non-atypical
epithelia. p62/SQSTM1 excess can cause low grade dysplasia in
the oral epithelium to develop into carcinoma via the resistance to
various oxidative stresses. In order to investigate the association
between p62/SQSTM1 excess and the antioxidant system in oral
squamous epithelium, Nrf2 expression was analyzed. Nrf2 was
abundantly expressed in all the oral epithelial samples ranging
from normal epithelium to carcinoma. Nrf2 produces antioxidant
proteins, which provide resistance to the cytotoxicity caused by
oxidative stress, ROS, and/or subsequent DNA damage [11-13].
Oral squamous epithelium is ordinarily exposed to oxidative stress
from substances like tobacco and alcohol, and Nrf2 is constitu-
tively expressed in such epithelium [7]. Nevertheless, the
association of Nrf2 with oral epithelial carcinogenesis has not
been adequately explained.
In order to precisely explore a p62/SQSTM1 contribution to
the Nrf2 pathway in oral epithelial carcinogenesis, p62/SQSTM1
knockdowns were designed in oral cancer cells, where p62/
SQSTM1 was highly expressed. It has been reported that p62/
SQSTM1 accumulates and activates Nrf2 by competing with Nrf2
for its binding to Keap1 [25]. Under 10 Gy X-ray irradiation,
Keap1 was abundant in p62/SQSTM1-knockdown cells, and it
seems likely that p62/SQSTM1 insufficiency could reduce Keap1
degradation through a dysfunctional autophagic-lysozome path-
way. However, the present study demonstrated that p62/
SQSTM1 knockdowns did not largely affect active Nrf2 and the
associated antioxidant proteins (NQO1 and HO-1) under normal
culture conditions and 10 Gy X-ray irradiation. The data
suggested, therefore, that p62/SQSTM1 does not contribute
significantly to Nrf2 activity and the associated pathway in oral
cancer cells.
The oral cancer cell growth was inhibited by p62/SQSTM1
knockdowns especially under X-ray irradiated conditions. This
result suggested that p62/SQSTM1 may play an important role in
oral cancer cell survival. GSH content is tightly regulated in the
maintenance of the cellular redox status [30] and has been
implicated in protection against environmental oxidant-mediated
injuries [31]. Normally, in cells and tissues, more than 90% of the
total glutathione pool is in the reduced form, GSH, and less than
10% exists in the disulfide form, GSSG. Changes in the ratios of
both GSH and GSSG can broadly affect signaling pathways
participating in physiological responses associated with cell
proliferation, autophagy and apoptosis [31]. Therefore, the
present study focused on understanding the association between
GSSG-GSH and p62/SQSTM1 in X-ray irradiated oral cancer
cells producing ROS.
p62/SQSTM1 knockdown significantly reduced GSH contents
and increased ROS levels in oral cancer cells. Especially under X-
ray irradiated conditions, GSH induction was never seen in the
knockdown cells, although GSH levels were maintained in the
control cells. These data suggested that in control cells GSH
induction responded to X-ray irradiation in order to diminish the
produced ROS, and that p62/SQSTM1 insufficiency resulted in
failure to induce GSH and failure to protect the oral carcinoma
cells from cytotoxic stress. In other words, p62/SQSTM1 excess
cannot play a role in Nrf2 accumulation, but it instead helps to
sustain GSH concentration in response to ROS in the oral cancer
cells. Apoptotic cell death could not be detected under X-ray
irradiated conditions in oral cancer cells, but the prominent
accumulation of .G2/M phase cells was shown especially in p62/
SQSTM1-knockdown cells, suggesting catastrophic growth-inhi-
bition. Probably, insufficient p62/SQSTM1 causes GSH deficit,
ROS accumulation, and the resultant growth-inhibition known as
mitotic catastrophe.
It has been reported that p62/SQSTM1 regulates predomi-
nantly GSH production rather than Nrf2 accumulation in retinal
pigment epithelial cells [32], where photo-oxidative stresses are
abundant. Similarly, p62/SQSTM1 did not only correlate with
Nrf2, but also contributed more prominently to increase GSH
contents in the clinical samples of the present study. Therefore, in
oral epithelial cells, Nrf2 proteins are maintained against ordinary
oxidative stresses. In such oxidative environments, p62/
SQSTM1 predominantly induces sufficient amounts of GSH to
destroy various strong cytotoxic stresses caused by radiation or
chemotherapy, and then contributes to oral epithelial carcino-
genesis.
Finally, in order to clarify whether excessive p62/SQSTM1
could be associated with a clinically poor prognosis in oral cancer
cases, the cohort study was performed. In fact, classical immuno-
histochemical evaluation of p62/SQSTM1 can provide a predictive
benefit in the clinical management of oral cancer patients, and
further analysis validating the clinical prognostic value will be
warranted. It has been reported that there is an association between
p62/SQSTM1 staining and clinical survival in lung cancers [33].
Similarly, the present study indicates a possible predictive value of
p62/SQSTM1, and additionally suggests that excess p62/
SQSTM1 appears to be correlated with the resistance to oxidant
stresses caused by radiotherapeutic treatments.
of shRNA for p62/SQSTM1. Left and middle panels indicate the data on SAS and CAL27, respectively. The data on TIG-121 are displayed as a reference
at the right panels. In the WST-8 assays, mean absorbance values (OD450) 6 SE are shown vertically, and the number of days after exposure to
radiation is indicated horizontally. The values are derived from quadruplicate experiments (*, p,0.05, one-way factorial ANOVA and multiple
comparison tests accompanied by Scheffe’s significance test).
doi:10.1371/journal.pone.0074398.g003
p62/SQSTM1 and Oral Carcinogenesis
PLOS ONE | www.plosone.org 8 September 2013 | Volume 8 | Issue 9 | e74398
Figure 4. GSH cannot be induced by the irradiation, and ROS accumulate in p62/SQSTM1 knockdown cells. (A) GSSG (upper) and GSH
(lower) levels of shRNAs (sh-control, sh-p62(1) and sh-p62(2); blue, red and brown columns, respectively) -treated cells are indicated by bar chart. In
each graph, the left 3 columns indicate the data of no radiation. The middle 3 and right 3 columns indicate the data of 5-10 Gy X-ray irradiation
followed by 24h culture. Although GSH was maintained in sh-control cells, it was significantly reduced in sh-p62(1) and sh-p62(2) cells. The values are
derived from triplicate experiments (*, p,0.05, one-way factorial ANOVA and multiple comparison tests accompanied by Scheffe’s significance test).
(B) ROS levels were detected with CellROXH Green reagent in sh-control and sh-p62 cells, under no radiation (upper) and 5 (middle) - 10 (lower) Gy X-
ray irradiation. ROS levels in p62/SQSTM1 knockdown cells (red lines) were higher than in control cells (blue lines). Numbers indicate mean
fluorescent values. (C) DNA contents were evaluated with Hoechst 33342 reagent in sh-control and sh-p62 cells, under no radiation (upper) and 5
(middle) - 10 (lower) Gy X-ray irradiation. The more cells were irradiated, the more prominently .G2/M phase cell fractions were accumulated. The
accumulation was more prominent in p62/SQSTM1 knockdown cells (sh-p62; red lines) than in the control cells (sh-control; blue lines). Sub-G1
apoptotic fractions could not be detected. Left and right panels indicate the data on SAS and CAL27 cells, respectively.
doi:10.1371/journal.pone.0074398.g004
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p62/SQSTM1 excess may play a role in oral epithelial
carcinogenesis through the corresponding GSH induction in
response to cytotoxic stresses such as radiation or chemotherapy.
Immunohistochemical evaluation of p62/SQSTM1 may prove to
be a potentially significant test that will help to identify early
carcinogenesis, chemo-radiotherapeutic resistance or poor prog-
nosis of oral squamous cell carcinomas.
Supporting Information
Figure S1 PLA signals of each case were adequately
counted. Representative pathological regions of each case were
reviewed by two pathology specialists (M.T. and H.O.), and 3-4
typical regions of each case were digitally photo-imaged (upper
and middle rows). PLA signals of every image were counted
semiautomatically using the software BlobFinder (lower row). The
mean PLA signals from 3-4 images of each case were recognized as
the case-originated values (RCPs/cell).
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